Lexaria Bioscience (LEXX) Financial Statements

Lexaria Bioscience's market cap is currently $14.50M. The company's EPS TTM is $-0.583; its P/E ratio is -0.88; Lexaria Bioscience is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.